Levetiracetam Aurobindo

Levetiracetam, the active ingredient in Levetiracetam Aurobindo, is an anticonvulsant presented as an oral tablet for oral use. It is indicated for the treatment of partial, generalized tonic‑clonic and myoclonic seizures in patients requiring seizure control. GNH USA supplies Levetiracetam Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an anticonvulsant that acts on neuronal excitability to control various seizure types. - Partial seizures: reduces the frequency of focal onset seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: diminishes rapid, involuntary muscle jerks.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired. - Somnolence: increased sleepiness. - Headache: mild to moderate head pain. - Irritability: mood changes or agitation. - Nausea: upset stomach.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: serious skin disorder. - Blood dyscrasias: abnormal blood counts. - Suicidal thoughts: emergent mood disturbances. - Severe skin rash: extensive erythema or blistering. - Multi‑organ hypersensitivity: systemic inflammatory response.

Before initiating therapy, clinicians should evaluate individual risk factors and monitor for specific concerns. - Renal impairment: adjust dose according to renal function. - Hepatic dysfunction: monitor liver enzymes regularly. - Psychiatric symptoms: watch for mood changes, depression, or aggression. - Pregnancy: risk category unknown; use only if benefit outweighs potential risk. - Concomitant CNS depressants: may increase sedation. - Store at ambient temperature: keep in original container, protect from moisture and light.

Levetiracetam can interact with other medicines, influencing its effectiveness or safety.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma levels. - Phenobarbital: can reduce therapeutic effect. - Phenytoin: may decrease levetiracetam concentration.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Other antiepileptic drugs: dose adjustments may be required. - Renal excretion inhibitors: monitor renal function and drug levels.